share_log

$1.8M Bet On This Health Care Stock? Check Out These 3 Penny Stocks Insiders Are Aggressively Buying

$1.8M Bet On This Health Care Stock? Check Out These 3 Penny Stocks Insiders Are Aggressively Buying

180萬美元的股票賭注？看看這3只股票內部人士正在大力購買
Benzinga ·  06/14 19:15

The Dow Jones index closed lower by around 0.2% on Thursday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.

道瓊斯指數週四下跌約0.2%。當內部人員購買或出售股票時，表明他們對公司前景的信心或擔憂。對於對小盤股感興趣的投資者和交易員，可以考慮這一因素作爲他們整體投資或交易決策的因素。

Below is a look at a few recent notable insider transactions for penny stocks. For more, check out Benzinga's insider transactions platform.

以下是幾個近期關於低價股的值得關注的內部交易。了解更多，請查看Benzinga內幕交易平台。

Aclaris Therapeutics

aclaris therapeutics

  • The Trade: Aclaris Therapeutics, Inc. (NASDAQ:ACRS) 10% owner Braden Michael Leonard bought a total of 1,611,200 shares at an average price of $1.11. To acquire these shares, it cost around $1.78 million.
  • What's Happening: On May 7, Aclaris Therapeutics posted upbeat quarterly results.
  • What Aclaris Therapeutics Does: Aclaris Therapeutics Inc is a clinical-stage biopharmaceutical company that operates in the United States.
  • 交易：aclaris therapeutics, inc. (納斯達克：acrs)的10%所有人braden michael leonard以1.11美元的平均價格購買了1611200股。爲了收購這些股票，花費了約178萬美元。
  • 最新情況：5月7日，aclaris therapeutics發佈了樂觀的季度業績。
  • aclaris therapeutics inc是一家在美國運營的臨床階段生物製藥公司。

Zomedica

zomedica

  • The Trade: Zomedica Corp. (NYSE:ZOM) Vice President of Sales Russell Kevin Klass acquired a total of 299,993 shares at an average price of $0.16. To acquire these shares, it cost around $46,529.
  • What's Happening: On May 15, Zomedica announced the launch of Over-the-Air software and firmware update capability for its TRUFORMA point-of-care diagnostic platform.
  • What Zomedica Does: Zomedica Corp is a veterinary health company creating products for companion animals (canine, feline and equine) by focusing on the unmet needs of clinical veterinarians.
  • 交易：zomedica corp. (紐交所：zom)銷售副總裁russell kevin klass以0.16美元的平均價格收購了299993股。爲了收購這些股票，花費了約46529美元。
  • 最新情況：5月15日，zomedica宣佈爲其truforma診斷平台推出空中軟件和固件更新功能。
  • zomedica corp是一家獸醫健康公司，通過關注臨床獸醫的未滿足需求，爲伴侶動物（犬、貓和馬）創建產品。

Perspective Therapeutics

Perspective Therapeutics

  • The Trade: Perspective Therapeutics, Inc. (NASDAQ:CATX) CEO Johan M. Spoor acquired a total of 100,000 at an average price of $1.17. The insider spent around $117,430 to buy those shares.
  • What's Happening: On June 11, Perspective Therapeutics announced a 1-for-10 reverse stock split.
  • What Perspective Therapeutics Does: Perspective Therapeutics Inc is a medical technology and radiopharmaceutical company that is pioneering various treatment applications for cancers throughout the body.
  • 交易：perspective therapeutics，inc. (納斯達克：catx)的ceo johan m. Spoor以1.17美元的平均價格購買了100000股。內部人士花費約117430美元購買這些股票。
  • 最新情況：6月11日，perspective therapeutics宣佈進行1比10的股票逆向拆分。
  • Perspective Therapeutics Inc是一家醫療技術和放射性製劑公司，正在開發治療全身各種癌症的各種治療應用。

Now Read This: Top 3 Tech Stocks That May Fall Off A Cliff This Month

現在閱讀這篇文章：三大可能在本月下跌的科技股。

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論